COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Imagene Advances LungOI Commercialization With New Payment Code and Pricing, Complementing Its Prior CLIA Certified US Lab
Imagene's LungOI AI-based NSCLC Biomarker Profiling Test receives Medicare payment rate, positioning it as a leading LDT product for lung genomic alterations detection -
COMMUNIQUÉ DE PRESSE
FSD Pharma Submits a Clinical Trial Protocol to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication
FSD Pharma submits clinical trial protocol for Unbuzzd(TM) to assess safety and efficacy in a crossover design trial to study effects on alcohol intoxication. Dr. Andrzej Chruscinski comments on the milestone reached -
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Nextech3D.ai Announces The Closing of Map Dynamics Sale to ARway.ai To Focus on Patented High-Margin Generative AI-powered 3D Modeling Technology
Nextech3D.ai announces the sale of Map Dynamics to ARway.ai for $1.2 million in stock, streamlining operations and focusing on AI 3D technology. This strategic move enhances both companies' financial positions
